Telo Genomics Corp TDSGF:OTCQB

*Data is delayed | Exchange | USD
Last | 9:54 AM EDT
0.115UNCH (UNCH)
Volume
10,500
52 week range
0.08 - 0.24
Loading...
  • Open0.115
  • Day High0.115
  • Day Low0.115
  • Prev Close0.115
  • 52 Week High0.24
  • 52 Week High Date06/13/23
  • 52 Week Low0.08
  • 52 Week Low Date03/11/24

Key Stats

  • Market Cap7.84M
  • Shares Out71.31M
  • 10 Day Average Volume21,196.67
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-17.86

KEY STATS

  • Open0.115
  • Day High0.115
  • Day Low0.115
  • Prev Close0.115
  • 52 Week High0.24
  • 52 Week High Date06/13/23
  • 52 Week Low0.08
  • 52 Week Low Date03/11/24
  • Market Cap7.84M
  • Shares Out71.31M
  • 10 Day Average Volume21,196.67
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-17.86

RATIOS/PROFITABILITY

  • EPS (TTM)-0.04
  • P/E (TTM)-3.25
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Telo Genomics Corp

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Telo Genomics Corp. is a Canada-based biotech company. The Company is focused on the development and commercialization of predictive technological products designed to personalize treatment plans for patients who have specific conditions. The Company, through its wholly owned subsidiary, Telo Genomics Holdings Corp., is developing diagnostic and prognostic products for diseases that display genomic instability. Its lead product, TeloView SMM, is a high-complexity molecular...
Guido Baechler
Chairman of the Board
Sabine Mai Ph.D.
Interim Chief Executive Officer, Director, Chair of the Clinical and Scientific Advisory Board
Sherif Louis
President, Chief Technology Officer
Christopher Ross CPA
Chief Financial Officer
Address
Mars Centre, 101 College St Suite 200
Toronto, ON
M5G 1L7
Canada